Diametric Capital’s Precigen PGEN Stock Holding History

Diametric Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.05M	Buy	+1,412,000	New	+$6.1M	0.85%	11

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

Diametric Capital's PGEN Position: Q2 2026 in Review

Diametric Capital increased its Precigen (PGEN) stake by 36% in Q2 2026, buying an estimated $10.7M and bringing the position to 9,269,926 shares worth $52.8M. The position accounts for 5.57% of the portfolio, ranked #2.

Diametric Capital first reported a position in PGEN in Q4 2023 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Diametric Capital held 9,269,926 shares of Precigen worth $52.8M as of Q2 2026.
Diametric Capital bought 2,468,138 Precigen shares in Q2 2026, an estimated $10.7M.
Precigen made up 5.57% of Diametric Capital's portfolio in Q2 2026, its #2 holding.
Diametric Capital first reported a position in Precigen in Q4 2023 and has held it in 6 quarters since.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.